198 related articles for article (PubMed ID: 17996201)
1. Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans.
Yang SF; Hsieh YS; Lue KH; Chu SC; Chang IC; Lu KH
Clin Biochem; 2008 Jan; 41(1-2):109-16. PubMed ID: 17996201
[TBL] [Abstract][Full Text] [Related]
2. Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
Hsieh YS; Yang SF; Lue KH; Chu SC; Lu KH
J Orthop Res; 2008 Apr; 26(4):475-84. PubMed ID: 17975844
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis.
Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH
J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841
[TBL] [Abstract][Full Text] [Related]
4. Glucosamine sulfate suppresses the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
Chu SC; Yang SF; Lue KH; Hsieh YS; Lee CY; Chou MC; Lu KH
Clin Chim Acta; 2006 Oct; 372(1-2):167-72. PubMed ID: 16756968
[TBL] [Abstract][Full Text] [Related]
5. Naproxen, meloxicam and methylprednisolone inhibit urokinase plasminogen activator and inhibitor and gelatinases expression during the early stage of osteoarthritis.
Chu SC; Yang SF; Lue KH; Hsieh YS; Li TJ; Lu KH
Clin Chim Acta; 2008 Jan; 387(1-2):90-6. PubMed ID: 17963739
[TBL] [Abstract][Full Text] [Related]
6. Expression changes of gelatinases in human osteoarthritic knees and arthroscopic debridement.
Hsieh YS; Yang SF; Chu SC; Chen PN; Chou MC; Hsu MC; Lu KH
Arthroscopy; 2004 May; 20(5):482-8. PubMed ID: 15122138
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
[TBL] [Abstract][Full Text] [Related]
8. Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee.
Chu SC; Yang SF; Lue KH; Hsieh YS; Wu CL; Lu KH
Connect Tissue Res; 2004; 45(3):142-50. PubMed ID: 15512768
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP-2 and MMP-9 by synovial cells: a possible cause of joint damage after intra-articular hemorrhage.
Tajima T; Yoshida E; Yamashita A; Ohmura S; Tomitaka Y; Sugiki M; Asada Y; Maruyama M
J Orthop Res; 2005 Jul; 23(4):891-8. PubMed ID: 16023005
[TBL] [Abstract][Full Text] [Related]
11. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
[TBL] [Abstract][Full Text] [Related]
12. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
13. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
[TBL] [Abstract][Full Text] [Related]
14. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
[TBL] [Abstract][Full Text] [Related]
15. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
[TBL] [Abstract][Full Text] [Related]
16. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.
Bianchi M; Broggini M; Balzarini P; Franchi S; Sacerdote P
Int J Clin Pract; 2007 Aug; 61(8):1270-7. PubMed ID: 17590218
[TBL] [Abstract][Full Text] [Related]
17. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.
Blom AB; van Lent PL; Libregts S; Holthuysen AE; van der Kraan PM; van Rooijen N; van den Berg WB
Arthritis Rheum; 2007 Jan; 56(1):147-57. PubMed ID: 17195217
[TBL] [Abstract][Full Text] [Related]
18. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts.
Pelletier JP; Mineau F; Fernandes J; Kiansa K; Ranger P; Martel-Pelletier J
Clin Exp Rheumatol; 1997; 15(4):393-8. PubMed ID: 9272300
[TBL] [Abstract][Full Text] [Related]
19. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.
Mastbergen SC; Jansen NW; Bijlsma JW; Lafeber FP
Arthritis Res Ther; 2006; 8(1):R2. PubMed ID: 16356188
[TBL] [Abstract][Full Text] [Related]
20. Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.
Diehl P; Hantke B; Hennig M; Tschesche H; Mittelmeier W; Schmitt M; Muehlenweg B
Int J Mol Med; 2004 May; 13(5):711-5. PubMed ID: 15067375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
